GÖRG advises Prolupin in a financing round with participation of Capricorn Partners and Novax
GÖRG Partnerschaft von Rechtsanwälten mbB advised Prolupin in a further financing round under the lead of Munich partner Dr. Bernt Paudtke.
A double-digit million amount was invested in the financing round. The financing round was led by Capricorn Partners and Novax. The current investors Munich Venture Partners and eCAPITAL also participated in the financing round.
Advisors Prolupin GmbH
GÖRG Partnerschaft von Rechtsanwälten mbB
Dr. Bernt Paudtke, Partner, Corporate/M&A, Munich
Dr. Christian Glauer, Associated Partner, Corporate/M&A , Munich
Anne Schönfleisch, LL.B., Associated Partner, IP/IT, Berlin
Tobias Reichenberger, Associate, Corporate/M&A , Munich
Baker & McKenzie Advokatbyrå
Anna Orlander, Partner, M&A/Corporate, Stockholm
Baker & McKenzie Partnerschaft von Rechtsanwälten und Steuerberatern mbB
Dr. Jon Marcus Meese, Partner, M&A/Corporate, Munich
Dr. Tino Marz, Counsel, M&A/Corporate, Munich
About Prolupin GmbH
Prolupin is a spin out from the Fraunhofer-Institut für Verfahrenstechnik und Verpackung (IVV) in Munich with deep scientific expertise and a patent protected process for producing protein isolates from lupines. The company produces and markets a range of purely plant-based non-dairy alternatives to yoghurts, milks, ice creams and cream cheeses to address the growing demand for tasty plant-based foods for consumers focused on health and sustainability.
About Capricorn Partners
Capricorn Partners is an independent European manager of venture capital and equity funds, investing in innovative European companies with technology as competitive advantage. The investment team of Capricorn is composed of experienced investment managers with deep technology expertise and a broad industrial experience. Capricorn Partners is managing the venture capital funds Capricorn Sustainable Chemistry Fund, Capricorn Digital Growth Fund, Capricorn ICT Arkiv, Capricorn Health-tech Fund and Capricorn Cleantech Fund. In addition, it is the management company of Quest for Growth, quoted on NYSE Euronext Brussels, and the investment manager of Quest Cleantech Fund and Quest+, sub‐funds of Quest Management SICAV, registered in Luxembourg.
A long-term investor and partner to fast-growing businesses across Europe with strong teams, sector-leading positions and high-impact potential. Founded in 1999 and based in Stockholm, Novax is a part of the Swedish Axel Johnson Group. Investments include Academic Work, ApoEx, Bruce, Filippa K, Hedvig, Matsmart, Leeroy, RCO, STC and Voyado. Through our long-term and thesis-driven devotion to a limited number of sectors, we are committed to support pioneering businesses on their journeys toward market-leadership over the long-haul.
About Munich Venture Partners
Munich Venture Partners is a European venture capital investor backing entrepreneurs driving the eco-industrial revolution with transformative technologies. The investment focus is on sectors with CO2 emission-intensive value chains: energy, mobility, agriculture and food, and industrial technologies. MVP has more than 15 years of experience investing in cleantech start-ups across Europe, including investments in recent success cases relayr and sonnen.
eCAPITAL is a Münster-based alternative investment fund manager (AIFM) in accordance with EU-directive EuVECA. As a leading German venture capital firm, eCAPITAL has supported innovative entrepreneurs in future-oriented industries since 1999. The firm focuses on rapidly growing companies in the areas of Software/IT, Cleantech, Industry 4.0 and New Materials. Currently, eCAPITAL manages six funds with a total of 220 million euros under management.